Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction

Mahmoud Ragab Darwish; Walaa Farid; Ahmed Mokhtar El-Kersh

doi:doi:10.11648/j.ccr.20210501.13

| Peer-Reviewed

Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction

Mahmoud Ragab Darwish, Walaa Farid, Ahmed Mokhtar El-Kersh

Published in Cardiology and Cardiovascular Research (Volume 5, Issue 1)

Received: 20 December 2020 Accepted: 30 December 2020 Published: 15 January 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. However, survival after acute STEMI has considerably improved due to increasing symptom recognition, accurate diagnosis and effective timely reperfusion. This study aimed to investigate the relation between the level of oxidative stress markers and coronary no-reflow after primary percutaneous coronary intervention for patients with acute myocardial infarction. Patients & Methods: This prospective cohort study included 90 patients admitted with acute STEMI at cardiovascular medicine department Naser Institute hospital, during the period from June 2018 till 12 months. Patients were divided into 2 groups according to the post primary PCI thrombolysis in myocardial infarction (TIMI) flow score into: Group I: 45 patients with no-reflow phenomenon. Group II: 45 patients with TIMI flow ≥ 2 after primary PCI. They all underwent primary PCI within 24 hours of presentation. Results: This study showed increased concentrations of Malondialdehide (MDA) in the circulation of patients with no-reflow indicating increased lipid peroxidation which could be attributed to a deficiency of antioxidant defense mechanism. In group I, pt with coronary no-reflow MDA level ranged from 2.8-4.5 nmol/mL with mean 3.9±1.5 nmol/mL, while in group II control group, MDA level ranged from 1.1 – 2.1 nmol/mL with mean 1.55±0.4 nmol/mL, there was statistically significant difference between the two groups (P value<0.004). Conclusions: no-reflow phenomenon after primary PCI can be predicted using the oxidative stress markers.

Published in	Cardiology and Cardiovascular Research (Volume 5, Issue 1)
DOI	10.11648/j.ccr.20210501.13
Page(s)	16-24
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Oxidative Stress, Percutaneous Coronary Intervention, St-elevation Myocardial Infarction

References

[1]	Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000; 36 (4): 1202–9.
[2]	Schram HCF, Hemradj V V., Hermanides RS, Kedhi E, Ottervanger JP. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction. Int J Cardiol. 2018; (2017): #pagerange#.
[3]	Esteves Filho A, Garcia DP, Martinez Filho EE. The no reflow phenomenon in the coronary arteries. Arq Bras Cardiol. 1999 Jan; 72 (1): 99–108.
[4]	Kloner RA. No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther 2011; 16: 244e50.
[5]	Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, et al. 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2383e9.
[6]	Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54: 281e92.
[7]	Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009; 47: 372e81.
[8]	Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581e90.
[9]	Hsu CH, Chi BC, Liu MY, Li JH, Chen CJ, Chen RY. Phosphine-induced oxidative damage in rats: role of glutathione. Toxicology2002; 179: 1-8.
[10]	Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004; 430: 97-103.
[11]	Erel O. A new automated colorimetric method for measuring totaloxidant status. Clin Biochem 2005; 38: 1103-11.
[12]	Kampa M, Nistikaki A, Tsaousis V, Maliaraki N, Notas G, Castanas E. A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol 2002; 2: 3.
[13]	Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-85.
[14]	Tatli E, Alicik G, Buturak A, Yilmaztepe M, Aktoz M. Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia? Scientific World Journal 2013; 160380 [PMID: 23431252 DOI: 10.1155/2013/160380].
[15]	Faha Crcmdmf. The Netter Collection of Medical Illustrations - Cardiovascular System: Volume 8, 2e (Netter Green Book Collection). Saunders; 2014.
[16]	Kumari SS, Menon VP. Changes in concentrations of lipid peroxides and activities of superoxide dismutase and catalase in isoproterenol induced myocardial infarction in rats. Ind J Exp Biol 1987; 25: 419–23.
[17]	Sharif D, Abu-Salem M, Sharif-Rasslan A, Rosenschein U. Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention. Eur Hear journal Acute Cardiovasc care. 2017.
[18]	Brunet J, Boily MJ, Cordeau S, Des Rosiers C. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic Biol Med 1995; 19: 627-638 [PMID: 8529922 DOI: 10.1016/0891-5849 (95)00077-B].
[19]	Rafizadeh, Abdi S, O, Peighambari M, Basiri H, Bakhshandeh H. Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention. Res Cardiovasc Med. 2015.
[20]	Wang JW, Zhou ZQ, Chen YD, Wang CH, Zhu XL. A risk score for No reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Clin Cardiol. 2015.
[21]	Han YL, Liu JN, Jing QM, Ma YY, Jiang TM, Pu K, et al. The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay. Cardiovasc Ther. 2013.
[22]	Sabin P, Koshy A, Gupta P, Heart - Indian, 2017 U. Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. 2017 Apr; 69 Suppl 1 (Suppl 1): S34-S45.
[23]	Celik T, Balta S, Mikhailidis DP, Ozturk C, Aydin I, Tok D, et al. The relation between no-reflow phenomenon and complete blood count parameters. Angiology. 2017.
[24]	Patterson MRGSC. Netter’s Cardiology 2nd Edition. second. 2010.
[25]	Schaaf MJ, Mewton N, Rioufol G, Angoulvant D, Cayla G, Delarche N, et al. Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients. J Cardiol. 2016.
[26]	Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007; 116 (9): 975–83.
[27]	Holmes Jr DR, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. J Am Coll Cardiol 1995; 26: 668–74.

Cite This Article

Plain Text BibTeX RIS

APA Style

Mahmoud Ragab Darwish, Walaa Farid, Ahmed Mokhtar El-Kersh. (2021). Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiology and Cardiovascular Research, 5(1), 16-24. https://doi.org/10.11648/j.ccr.20210501.13

Copy | Download

ACS Style

Mahmoud Ragab Darwish; Walaa Farid; Ahmed Mokhtar El-Kersh. Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiol. Cardiovasc. Res. 2021, 5(1), 16-24. doi: 10.11648/j.ccr.20210501.13

Copy | Download

AMA Style

Mahmoud Ragab Darwish, Walaa Farid, Ahmed Mokhtar El-Kersh. Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiol Cardiovasc Res. 2021;5(1):16-24. doi: 10.11648/j.ccr.20210501.13

Copy | Download

@article{10.11648/j.ccr.20210501.13,
  author = {Mahmoud Ragab Darwish and Walaa Farid and Ahmed Mokhtar El-Kersh},
  title = {Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction},
  journal = {Cardiology and Cardiovascular Research},
  volume = {5},
  number = {1},
  pages = {16-24},
  doi = {10.11648/j.ccr.20210501.13},
  url = {https://doi.org/10.11648/j.ccr.20210501.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210501.13},
  abstract = {Background: ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. However, survival after acute STEMI has considerably improved due to increasing symptom recognition, accurate diagnosis and effective timely reperfusion. This study aimed to investigate the relation between the level of oxidative stress markers and coronary no-reflow after primary percutaneous coronary intervention for patients with acute myocardial infarction. Patients & Methods: This prospective cohort study included 90 patients admitted with acute STEMI at cardiovascular medicine department Naser Institute hospital, during the period from June 2018 till 12 months. Patients were divided into 2 groups according to the post primary PCI thrombolysis in myocardial infarction (TIMI) flow score into: Group I: 45 patients with no-reflow phenomenon. Group II: 45 patients with TIMI flow ≥ 2 after primary PCI. They all underwent primary PCI within 24 hours of presentation. Results: This study showed increased concentrations of Malondialdehide (MDA) in the circulation of patients with no-reflow indicating increased lipid peroxidation which could be attributed to a deficiency of antioxidant defense mechanism. In group I, pt with coronary no-reflow MDA level ranged from 2.8-4.5 nmol/mL with mean 3.9±1.5 nmol/mL, while in group II control group, MDA level ranged from 1.1 – 2.1 nmol/mL with mean 1.55±0.4 nmol/mL, there was statistically significant difference between the two groups (P value<0.004). Conclusions: no-reflow phenomenon after primary PCI can be predicted using the oxidative stress markers.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction
AU  - Mahmoud Ragab Darwish
AU  - Walaa Farid
AU  - Ahmed Mokhtar El-Kersh
Y1  - 2021/01/15
PY  - 2021
N1  - https://doi.org/10.11648/j.ccr.20210501.13
DO  - 10.11648/j.ccr.20210501.13
T2  - Cardiology and Cardiovascular Research
JF  - Cardiology and Cardiovascular Research
JO  - Cardiology and Cardiovascular Research
SP  - 16
EP  - 24
PB  - Science Publishing Group
SN  - 2578-8914
UR  - https://doi.org/10.11648/j.ccr.20210501.13
AB  - Background: ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. However, survival after acute STEMI has considerably improved due to increasing symptom recognition, accurate diagnosis and effective timely reperfusion. This study aimed to investigate the relation between the level of oxidative stress markers and coronary no-reflow after primary percutaneous coronary intervention for patients with acute myocardial infarction. Patients & Methods: This prospective cohort study included 90 patients admitted with acute STEMI at cardiovascular medicine department Naser Institute hospital, during the period from June 2018 till 12 months. Patients were divided into 2 groups according to the post primary PCI thrombolysis in myocardial infarction (TIMI) flow score into: Group I: 45 patients with no-reflow phenomenon. Group II: 45 patients with TIMI flow ≥ 2 after primary PCI. They all underwent primary PCI within 24 hours of presentation. Results: This study showed increased concentrations of Malondialdehide (MDA) in the circulation of patients with no-reflow indicating increased lipid peroxidation which could be attributed to a deficiency of antioxidant defense mechanism. In group I, pt with coronary no-reflow MDA level ranged from 2.8-4.5 nmol/mL with mean 3.9±1.5 nmol/mL, while in group II control group, MDA level ranged from 1.1 – 2.1 nmol/mL with mean 1.55±0.4 nmol/mL, there was statistically significant difference between the two groups (P value<0.004). Conclusions: no-reflow phenomenon after primary PCI can be predicted using the oxidative stress markers.
VL  - 5
IS  - 1
ER  -

Copy | Download

Author Information

Mahmoud Ragab Darwish

Cardiology Department, Health Insurance, Tanta, Egypt
Walaa Farid

Cardiology Department, Menoufia University, Shebin Elkom, Egypt
Ahmed Mokhtar El-Kersh

Cardiology Department, Faculty of Medicine, Menofia University, Shebin Elkom, Egypt

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Mahmoud Ragab Darwish, Walaa Farid, Ahmed Mokhtar El-Kersh. (2021). Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiology and Cardiovascular Research, 5(1), 16-24. https://doi.org/10.11648/j.ccr.20210501.13

Copy | Download

ACS Style

Mahmoud Ragab Darwish; Walaa Farid; Ahmed Mokhtar El-Kersh. Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiol. Cardiovasc. Res. 2021, 5(1), 16-24. doi: 10.11648/j.ccr.20210501.13

Copy | Download

AMA Style

Mahmoud Ragab Darwish, Walaa Farid, Ahmed Mokhtar El-Kersh. Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction. Cardiol Cardiovasc Res. 2021;5(1):16-24. doi: 10.11648/j.ccr.20210501.13

Copy | Download

@article{10.11648/j.ccr.20210501.13,
  author = {Mahmoud Ragab Darwish and Walaa Farid and Ahmed Mokhtar El-Kersh},
  title = {Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction},
  journal = {Cardiology and Cardiovascular Research},
  volume = {5},
  number = {1},
  pages = {16-24},
  doi = {10.11648/j.ccr.20210501.13},
  url = {https://doi.org/10.11648/j.ccr.20210501.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210501.13},
  abstract = {Background: ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. However, survival after acute STEMI has considerably improved due to increasing symptom recognition, accurate diagnosis and effective timely reperfusion. This study aimed to investigate the relation between the level of oxidative stress markers and coronary no-reflow after primary percutaneous coronary intervention for patients with acute myocardial infarction. Patients & Methods: This prospective cohort study included 90 patients admitted with acute STEMI at cardiovascular medicine department Naser Institute hospital, during the period from June 2018 till 12 months. Patients were divided into 2 groups according to the post primary PCI thrombolysis in myocardial infarction (TIMI) flow score into: Group I: 45 patients with no-reflow phenomenon. Group II: 45 patients with TIMI flow ≥ 2 after primary PCI. They all underwent primary PCI within 24 hours of presentation. Results: This study showed increased concentrations of Malondialdehide (MDA) in the circulation of patients with no-reflow indicating increased lipid peroxidation which could be attributed to a deficiency of antioxidant defense mechanism. In group I, pt with coronary no-reflow MDA level ranged from 2.8-4.5 nmol/mL with mean 3.9±1.5 nmol/mL, while in group II control group, MDA level ranged from 1.1 – 2.1 nmol/mL with mean 1.55±0.4 nmol/mL, there was statistically significant difference between the two groups (P value<0.004). Conclusions: no-reflow phenomenon after primary PCI can be predicted using the oxidative stress markers.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Influence of Oxidative Stress Markers on Coronary No-reflow After Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction
AU  - Mahmoud Ragab Darwish
AU  - Walaa Farid
AU  - Ahmed Mokhtar El-Kersh
Y1  - 2021/01/15
PY  - 2021
N1  - https://doi.org/10.11648/j.ccr.20210501.13
DO  - 10.11648/j.ccr.20210501.13
T2  - Cardiology and Cardiovascular Research
JF  - Cardiology and Cardiovascular Research
JO  - Cardiology and Cardiovascular Research
SP  - 16
EP  - 24
PB  - Science Publishing Group
SN  - 2578-8914
UR  - https://doi.org/10.11648/j.ccr.20210501.13
AB  - Background: ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. However, survival after acute STEMI has considerably improved due to increasing symptom recognition, accurate diagnosis and effective timely reperfusion. This study aimed to investigate the relation between the level of oxidative stress markers and coronary no-reflow after primary percutaneous coronary intervention for patients with acute myocardial infarction. Patients & Methods: This prospective cohort study included 90 patients admitted with acute STEMI at cardiovascular medicine department Naser Institute hospital, during the period from June 2018 till 12 months. Patients were divided into 2 groups according to the post primary PCI thrombolysis in myocardial infarction (TIMI) flow score into: Group I: 45 patients with no-reflow phenomenon. Group II: 45 patients with TIMI flow ≥ 2 after primary PCI. They all underwent primary PCI within 24 hours of presentation. Results: This study showed increased concentrations of Malondialdehide (MDA) in the circulation of patients with no-reflow indicating increased lipid peroxidation which could be attributed to a deficiency of antioxidant defense mechanism. In group I, pt with coronary no-reflow MDA level ranged from 2.8-4.5 nmol/mL with mean 3.9±1.5 nmol/mL, while in group II control group, MDA level ranged from 1.1 – 2.1 nmol/mL with mean 1.55±0.4 nmol/mL, there was statistically significant difference between the two groups (P value<0.004). Conclusions: no-reflow phenomenon after primary PCI can be predicted using the oxidative stress markers.
VL  - 5
IS  - 1
ER  -

Copy | Download